Pneumococcal

The Pharmacy Times® Pneumococcal Resource Center is a comprehensive resource for clinical news and expert insights for any infection caused by the bacteria Streptococcus pneumoniae, or pneumococcus.

Pharmacy Clinical Pearl of the Day: Group B Streptococcus

February 03, 2022

Article

Group B strep can cause dangerous infections in adults with certain chronic medical conditions.

Study: More Than 1.2 Million People Died in 2019 From Antibiotic-Resistant Bacterial Infections Compared to HIV/AIDS, Malaria

January 27, 2022

Article

The analysis of 204 countries and territories reveals that AMR is now a leading cause of death worldwide, which is higher than HIV/AIDS or malaria.

Respiratory Viruses That Hijack Immune Mechanisms May Have Achilles’ Heel

January 19, 2022

Article

One viral protein could provide information to deter pneumonia causing the body’s exaggerated inflammatory response, new study results show.

Study: Infants With Low-Risk Deliveries May Not Need Antibiotics At Birth

January 17, 2022

Article

The findings could help clinicians tailor the use of early antibiotics in newborns because only infants deemed at risk for infection should receive antibiotics.

Pfizer Announces Positive Results With Coadministration of Prevnar 20, COVID-19 Vaccine

January 12, 2022

Article

Responses elicited by the pneumococcal vaccine for all 20 serotypes were similar whether administered with the COVID-19 vaccine or with placebo.

Pharmacist Medication Insights: Lefamulin (Xenleta) for Community-Acquired Bacterial Pneumonia

January 12, 2022

Video

Lefamulin (Xenleta, Nabriva Therapeutics) is approved for the treatment of adults with community-acquired bacterial pneumonia caused by susceptible microorganisms.

Study: Regular Exercise Reduces Risk, Death from Pneumonia

January 03, 2022

Article

The research team looked at a pooled analysis of all published studies to re-evaluate the relationship between regular exercise and the risk of developing pneumonia.

Study: Prognosis of Chronic Hypersensitivity Pneumonitis Linked to Genetic Variations

December 24, 2021

Article

Chronic hypersensitivity pneumonitis is a long-term lung condition in which the interstitial tissue surrounding the alveoli of the lungs becomes inflamed and develops fibrosis.

FDA Accepts Pneumococcal 15-Valent Conjugate Vaccine for Infants, Children for Priority Review

December 14, 2021

Article

Serotypes 22F, 33F, and 3 represent more than a quarter of invasive pneumococcal disease in children under the age of 5

Group B Streptococcus Major Source of Preterm Births, Disability, Infant Mortality

December 03, 2021

Article

Multiple GBS vaccine candidates are in development, but none are available despite development efforts spanning multiple decades.